HRTX
Heron Therapeuti
NASDAQ: HRTX · HEALTHCARE · BIOTECHNOLOGY
$1.19
-1.65% today
Updated 2026-04-29
Market cap
$224.36M
P/E ratio
—
P/S ratio
1.45x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$1 – $3
Volume
2.1M
Heron Therapeuti (HRTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-13.00%
Operating margin
0.09%
ROE
-2,409.00%
ROA
-0.65%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $5.39M | $5.27M | — | -349.92% | 97.68% |
| 2007 | $412000.00 | $-20.16M | 100.00% | -5,736.17% | -4,893.93% |
| 2008 | $369000.00 | $-23.13M | 100.00% | -6,353.66% | -6,266.94% |
| 2009 | $1.26M | $-10.03M | 100.00% | -812.21% | -795.24% |
| 2010 | $1.30M | $-7.35M | 100.00% | -763.57% | -564.64% |
| 2011 | $646000.00 | $-11.81M | 72.29% | -1,712.38% | -1,828.79% |
| 2012 | $-599000.00 | $-23.35M | 100.00% | 3,978.46% | 3,897.83% |
| 2013 | $0.00 | $-55.28M | — | — | — |
| 2014 | $0.00 | $-76.37M | — | — | — |
| 2015 | $0.00 | $-97.59M | — | — | — |
| 2016 | $1.28M | $-173.14M | 97.26% | -13,363.17% | -13,537.37% |
| 2017 | $30.77M | $-197.48M | 85.09% | -632.36% | -641.87% |
| 2018 | $77.47M | $-178.84M | 64.49% | -237.42% | -230.84% |
| 2019 | $145.97M | $-204.75M | 57.79% | -144.34% | -140.27% |
| 2020 | $88.64M | $-224.43M | 59.17% | -257.41% | -253.20% |
| 2021 | $86.35M | $-217.66M | 46.70% | -252.27% | -252.08% |
| 2022 | $107.67M | $-134.52M | 49.04% | -162.21% | -124.93% |
| 2023 | $127.04M | $-110.56M | 48.75% | -87.07% | -87.02% |
| 2024 | $144.28M | $-13.58M | 73.21% | -7.99% | -9.41% |
| 2025 | $154.90M | $-20.20M | 73.31% | -1.64% | -13.04% |